These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 24767223)

  • 21. Thyroid-associated ophthalmopathy in Iranian patients.
    Kashkouli MB; Jam S; Sabzvari D; Ketabi N; Azarinia S; SeyedAlinaghi S; Mofid A
    Acta Med Iran; 2011; 49(9):612-8. PubMed ID: 22052145
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quality of life in patients with thyroid eye disease.
    Bahmani-Kashkouli M; Pakdel F; Astaraki A; Hashemi M; Honarbakhsh Y; Mirarmandehi B; Jam S
    J Ophthalmic Vis Res; 2009 Jul; 4(3):164-8. PubMed ID: 23198067
    [TBL] [Abstract][Full Text] [Related]  

  • 23. How patients experience thyroid eye disease.
    Smith TJ; Hegedüs L; Lesser I; Perros P; Dorris K; Kinrade M; Troy-Ott P; Wuerth L; Nori M
    Front Endocrinol (Lausanne); 2023; 14():1283374. PubMed ID: 38027128
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Knowledge of Thyroid Eye Disease in Graves' Disease Patients With and Without Orbitopathy.
    Edmunds MR; Boelaert K
    Thyroid; 2019 Apr; 29(4):557-562. PubMed ID: 30688164
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of Quality of Life in the Brazilian Graves' Disease Population: Focus on Mild and Moderate Graves' Orbitopathy Patients.
    Villagelin D; Romaldini J; Andrade J; Santos R; Milkos A; Teixeira PFDS; Ward LS
    Front Endocrinol (Lausanne); 2019; 10():192. PubMed ID: 31024443
    [No Abstract]   [Full Text] [Related]  

  • 26. Teprotumumab for the treatment of thyroid eye disease.
    Fallahi P; Ragusa F; Paparo SR; Elia G; Balestri E; Mazzi V; Patrizio A; Botrini C; Benvenga S; Ferrari SM; Antonelli A
    Expert Opin Biol Ther; 2023 Feb; 23(2):123-131. PubMed ID: 36695097
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Grading Severity and Activity in Thyroid Eye Disease.
    Dolman PJ
    Ophthalmic Plast Reconstr Surg; 2018; 34(4S Suppl 1):S34-S40. PubMed ID: 29952931
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Which factors are associated with quality of life in patients with Graves' orbitopathy presenting for orbital decompression surgery?
    Wickwar S; McBain HB; Ezra DG; Hirani SP; Rose GE; Newman SP
    Eye (Lond); 2015 Jul; 29(7):951-7. PubMed ID: 25998940
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quality of life of patients with thyroid eye disease: 3-year follow-up in a multidisciplinary clinic in Israel.
    Zloto O; Sagiv O; Priel A; Cukierman-Yaffe T; Tirosh A; Agmon-Levin N; Madgar S; Serlin T; Ben Simon G
    Graefes Arch Clin Exp Ophthalmol; 2021 Jul; 259(7):2009-2015. PubMed ID: 33528651
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of quality of life and depression in Korean patients with Graves' ophthalmopathy.
    Lee H; Roh HS; Yoon JS; Lee SY
    Korean J Ophthalmol; 2010 Apr; 24(2):65-72. PubMed ID: 20379454
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Euthyroid graves' ophthalmopathy in a Chinese population: A cross-sectional follow-up study.
    Lai KK; Ali Abdulla Aljufairi FM; Sebastian JU; Chin JK; Choy EK; Yiu AH; Lee AC; Ng CM; Yip WW; Young AL; Yuen HK; Tham CC; Pang CP; Chong KK
    Eur J Ophthalmol; 2024 Sep; 34(5):1432-1437. PubMed ID: 38444235
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bilateral versus unilateral thyroid eye disease.
    Kashkouli MB; Kaghazkanani R; Heidari I; Ketabi N; Jam S; Azarnia S; Pakdel F
    Indian J Ophthalmol; 2011; 59(5):363-6. PubMed ID: 21836341
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of disease-specific quality of life and its influencing factors in Bulgarian patients with Graves' orbitopathy.
    Stoynova MA; Shinkov AD; Dimitrova ID; Yankova IA; Kovatcheva RD
    Int Ophthalmol; 2024 Feb; 44(1):68. PubMed ID: 38347322
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessing the quality of life in Indian Graves' orbitopathy patients and validation of Hindi version of GO-QOL questionnaire.
    Delampady K; Reddy SVB; Yadav SB
    Indian J Ophthalmol; 2020 Aug; 68(8):1617-1621. PubMed ID: 32709791
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characteristics of Diabetic and Nondiabetic Patients With Thyroid Eye Disease in the United States: A Claims-Based Analysis.
    Patel VK; Padnick-Silver L; D'Souza S; Bhattacharya RK; Francis-Sedlak M; Holt RJ
    Endocr Pract; 2022 Feb; 28(2):159-164. PubMed ID: 34781042
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A 'Real Life' Service Evaluation Model for Multidisciplinary Thyroid Eye Services.
    Farag S; Feeney C; Lee V; Nagendran S; Jain R; Aziz A; Akishar R; Bravis V; Meeran K
    Front Endocrinol (Lausanne); 2021; 12():669871. PubMed ID: 34025584
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Measurement of Medial Wall Bowing and Clinical Associations in Thyroid Eye Disease.
    Bokman CL; Ugradar S; Rootman DB
    Ophthalmic Plast Reconstr Surg; 2018; 34(6):557-559. PubMed ID: 29505466
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of quality of life in patients with Graves´ ophthalmopathy, before and after orbital decompression.
    Iacobæus L; Sahlin S
    Orbit; 2016 Jun; 35(3):121-5. PubMed ID: 27159575
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gender differences in clinical presentation and prognosis of thyroid eye disease.
    Zloto O; Sagiv O; Priel A; Cukierman-Yaffe T; Tirosh A; Agmon-Levin N; Madgar S; Serlin T; Ben Simon G
    Eur J Ophthalmol; 2021 Sep; 31(5):2717-2723. PubMed ID: 33158379
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expanding Understanding of Thyroid Eye Disease Manifestations to Include Hispanic and Black Patients.
    Goldstein T; Mostowy M; Tingley J; Rand G; Moon JY; Barmettler A
    Middle East Afr J Ophthalmol; 2022; 29(4):171-180. PubMed ID: 38162569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.